Porsche Crash Case: Maha Govt Approves Prosecution of Forensic Head, CMO, staff of Sassoon Hospital

Pune: In the latest update on the Porsche car crash case in Pune where the head of the Forensic Medicine department and Chief Medical Officer (CMO) of Pune-based Sassoon General Hospital were arrested for alleged manipulation of the blood sample of the teen driver, the Maharashtra government has informed a local court that it has permitted the Pune police to prosecute them and another staffer from the hospital. 

According to a recent news agency report, these trio, the juvenile’s parents and two middlemen are currently in jail in the case. The three staffers of Sasson Hospital are accused of being involved in the swapping of the minor’s blood samples to nullify alcohol tests. 

Medical Dialogues team had earlier reported that two doctors of Sassoon Hospital were arrested for allegedly discarding the blood samples of the 17-year-old boy suspect accused of murdering two software engineers and replacing them with another person’s samples.

Also read- Porsche Crash Case: Need official documents to initiate action against Forensic Head, CMO of Sassoon Hospital, says Medical Council

The two doctors accused of tampering with the blood sample reports include the head of the Forensic Medicine department of Sassoon General Hospital and the chief medical officer of the Sassoon Hospital.

During the investigation, it was revealed that the Chief Medical Officer reportedly replaced the blood samples on the direction of the HOD on 19th May at around 11 am. The CMO allegedly threw the blood samples in a dustbin of the hospital and sent the blood samples of another person to the forensic lab. As a result, the report showed no alcohol traces of the accused. Later, the state government suspended them based on the recommendation of the Maharashtra Medical Education Department commissioner.

Special public prosecutor advocate Shishir Hiray told PTI, “We today (on Thursday) submitted to the court that police have received the state government’s sanction to prosecute Taware, Halnor and Ghatkamble in the case. Such sanction to prosecute or frame charges against government employees is mandatory.”

Medical Dialogues had reported that no action was taken so far against the head of the Forensic Medicine department and Chief Medical Officer (CMO) of Pune-based Sassoon General Hospital by the Maharashtra Medical Council (MMC) in connection with the alleged manipulation of the blood sample of the teen driver involved in the May 19 Porsche car crash case.

On May 2024 the MMC issued notices to both doctors after taking suo moto cognizance of the matter. In the notice, the council had demanded a written explanation within seven days from the two doctors providing details for their alleged negligence following which actions were said to be taken accordingly.

Although the council received responses from the doctors, it is currently unable to take action against them until it receives an official response from the Pune police Commissioner and the Directorate of Medical Education and Research (DMER) in the case.

Also read- Porsche Crash Case: Crime Branch opposes bail plea of suspended Forensic Head of Sassoon Hospital

Powered by WPeMatico

Medical Bulletin 26 October/ 2024

Here are the top medical news for the day:

Want to Preserve Brain Health? Address Sleep Problems: AAN Study

People in early middle age who have poor sleep quality, including having difficulty falling or staying asleep, have more signs of poor brain health in late middle age, according to a study published online in Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that poor sleep accelerates brain aging. It only shows an association between poor sleep quality and signs of brain aging.

The study included 589 people with an average age of 40 at the start of the study. Participants completed sleep questionnaires both at the beginning of the study and again five years later. Participants had brain scans 15 years after the study began.

Researchers reviewed participants’ responses to questions such as, “Do you usually have trouble falling asleep?” “Do you usually wake up several times at night?” and “Do you usually wake up far too early?” They recorded the number of six poor sleep characteristics for each participant: short sleep duration, bad sleep quality, difficulty falling asleep, difficulty staying asleep, early morning awakening and daytime sleepiness.

Participants were divided into three groups. Those in the low group had no more than one poor sleep characteristic. People in the middle group had two to three, and those in the high group had more than three. At the start of the study, about 70% were in the low group, 22% were in the middle and 8% were in the high group.

Researchers examined participants’ brain scans where the level of brain shrinkage corresponds to a specific age. Researchers used machine learning to determine the brain age for each participant.

After adjusting for factors such as age, sex, high blood pressure and diabetes, researchers found people in the middle group had an average brain age that was 1.6 years older than those in the low group, while those in the high group had an average brain age 2.6 years older.

Of the sleep characteristics, bad sleep quality, difficulty falling asleep, difficulty staying asleep and early morning awakening were linked to greater brain age, especially when people consistently had these poor sleep characteristics over five years.

Urine Test May Reveal Early Signs of Genitourinary Diseases: Study finds

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford University, studying the RNA and other substances within urine can show changes in cell types, revealing early signs of cancer and other diseases. This method could help clinicians detect problems earlier when they are more easily treated without invasive procedures.

“The current gold standard for detecting many genitourinary ailments is a biopsy where small tissue is removed during a rectal exam and sent to the lab for analysis. The invasive nature of the test can scare some people from getting the care they need,” said Joseph Buonomo, assistant professor of chemistry at UTA and an author of the study. “Our preliminary research shows that studying the RNA found in urine can detect some ailments in their earliest stages where they are easily—and cost effectively—managed.”

In the study, the team collected urine samples from two groups of people – healthy individuals and people with kidney stones. Researchers took two types of RNA from the urine – cell-free RNA that floats freely in urine, and sediment RNA, which comes from solid particles. The types of RNA were then sequenced and analyzed, comparing the specimens from the healthy individuals to the ones with kidney stones. They found that advanced urine analyses identified patterns in cells indicative of whether a person has disease.

“We’re excited about this new research as it may lead to new, easier screening tools that can help detect diseases of the bladder, kidneys, and prostate,” said Buonomo. “Although our patient cohort was small, it lays the groundwork for development of a type of ‘non-invasive liquid biopsy’ that will be used to track the progression of ailments like kidney stones, diabetes, and cancer using urine instead of surgical specimens.”

Reference: Sevahn K Vorperian, Brian C DeFelice, Joseph A Buonomo, Hagop J Chinchinian, Ira J Gray, Jia Yan, Kathleen E Mach, Vinh La, Timothy J Lee, Joseph C Liao, Richard Lafayette, Gabriel B Loeb, Carolyn R Bertozzi, Stephen R Quake, Deconvolution of Human Urine across the Transcriptome and Metabolome, Clinical Chemistry, 2024;, hvae137, https://doi.org/10.1093/clinchem/hvae137

Why Our Brains Are Effective at Quickly Processing Short Messages?

A new study by a team of New York University linguistics and psychology researchers has discovered that when a brief sentence is flashed, our brains detect its basic linguistic structure extremely quickly — in roughly 150 milliseconds, or about the speed of a blink of an eye.

“Our experiments reveal that the brain’s language comprehension system may be able to perceive language similarly to visual scenes, whose essence can be grasped quickly from a single glance,” says Liina Pylkkänen, a professor in NYU’s Department of Linguistics and Department of Psychology, who led the research, which is reported across papers appearing in Science Advances and the Journal of Neuroscience. “This means the human brain’s processing capacity for language may be much faster than what we might think — in the amount of time it takes to hear one syllable, the brain can actually detect the structure of a short sentence.”

The scientists began their research by considering current scientific explanations of how we understand language, which center on word-by-word sentence processing models. The researchers concluded these don’t effectively account for how quickly our brains can process entire sentences seen at a glance, as opposed to word by word like in speech.

In seeking a better understanding, the authors conducted a series of experiments, measuring brain activity using magnetoencephalography while participants read word lists that were either grammatical sentences or just lists of nouns. The results showed that the brain’s left temporal cortex — used for language comprehension — starts distinguishing simple three-word sentences from unstructured word lists as quickly as 130 milliseconds after seeing them.

“This speed suggests that at-a-glance sentence comprehension may resemble the rapid perception of a visual scene rather than the slower, step-by-step process we associate with spoken language,” explains Pylkkänen. “In the amount of time that it takes one to hear one syllable, the brain can actually detect the structure of a three-word sentence.”

Can Loss of Sleep Impact Brain Development in Babies?

A new study led by Sean Gay, a graduate student in the lab of Graham Diering, PhD, assistant professor in the Department of Cell Biology and Physiology at the UNC School of Medicine, has given us insights into how sleep loss during early life impacts key parts of brain development – and how it can also increase one’s risk for developing autism spectrum disorder (ASD). Their findings were published in the Proceedings of the National Academy of Sciences.

“The unique effects of sleep loss during development are largely unexplored,” said Diering. “Our data show that babies and children are more vulnerable to the negative effects of sleep disruption. We also found that sleep loss during this crucial period of time can negatively interact with underlying genetic risk for autism spectrum disorder.”

Diering has long studied how sleep strengthens synapses over time – a process termed synaptic plasticity – and how lack of sleep can contribute to cognitive and neurodegenerative disorders. If researchers could better understand the links between sleep and ASD, researchers and physicians also could make earlier diagnoses and come up with new treatment strategies for the disorder.

Using specialized mouse houses with highly sensitive sensors, researchers were able to carefully track mouse movements and breathing, allowing the researchers to keep score of wake and sleep states.

Researchers showed that when the adult mouse models lost a significant amount of sleep, they compensated for it by increasing sleep later during their regular active hours. Termed “sleep rebound”, this response allowed the adults to “make up” for lost sleep.

The younger mice; on the other hand, lacked sleep rebound entirely. This confirmed the researcher’s hypothesis that the younger mice might be more susceptible to the harmful effects of sleep deprivation. Researchers also noted that sleep deprivation in young mice completely impaired their performance in a learning memory task, whereas adults were far more resilient after sleep loss.

Reference: Gay, S. M., Chartampila, E., Lord, J. S., Grizzard, S., Maisashvili, T., Ye, M., … & Diering, G. H. (2023). Developing forebrain synapses are uniquely vulnerable to sleep loss. bioRxiv, 2023-11.

Powered by WPeMatico

Biocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics

Bengaluru: Biocon Foundation, the CSR arm of the Biocon Group of Companies, announced that it has received the esteemed ‘Doing Good for Bharat Awards’ 2024 in the Healthcare category for its eLAJ Smart Clinics initiative, which aims to reimagine healthcare for underserved communities. The award was presented at the 11th India CSR & ESG Summit, organized by CSRBOX in New Delhi. 

The award was received by Shefali Misra, Vice President – Corporate Affairs, Biocon on behalf of Biocon Foundation, from Shri Dinesh Gundu Rao, Hon’ble Minister of Health & Family Welfare, Government of Karnataka, Shri (Dr) Raj Bhushan Choudhary, Hon’ble Union Minister of State Jal Shakti, Government of India, and Hon’ble Padma Shri Savji Dholakia, Founder and Chairman, Hare Krishna Exports & Dholakia Foundation.
This accolade recognizes Biocon Foundation’s significant contributions to primary healthcare through its unique eLAJ – Smart Clinics and highlights its deep commitment to making a difference in the lives of people. Biocon Foundation launched eLAJ Smart Clinics program in 2016 to enhance evidence-based preventive and primary healthcare. It has catered to over one million people across seven districts in Karnataka, with 8.8 lakh patient visits by 3.4 lakh unique patients.
On receiving the award, Dr Anupama Shetty, Mission Director, Biocon Foundation said, “It is an immense honor to be recognized at the ‘Doing Good for Bharat Awards’ 2024 by CSR Box. This award reaffirms our commitment to eLAJ – our initiative focused on supporting the primary healthcare infrastructure for the underserved community. We believe that quality healthcare is a fundamental right and are grateful to CSRBOX and the esteemed jury for acknowledging our work and impact. This award motivates us to continue expanding our reach and enhancing healthcare services, ensuring that more people have access to the care they deserve. We remain dedicated to making a meaningful difference across communities.”
The ‘Doing Good for Bharat Awards’, celebrate outstanding achievements in areas such as climate, education, healthcare, rural development, and inclusion. This year’s award ceremony recognized impact professionals, businesses, government entities, and civil society organizations for their dedicated efforts in creating a more inclusive and sustainable Bharat. The Awards aim to inspire more organizations to take bold and innovative steps in addressing social and environmental challenges.
Bhomik Shah, Founder & CEO, CSRBOX, highlighted the importance of these awards, stating, “The ‘Doing Good for Bharat Awards’ spotlight organizations that are making meaningful, tangible impacts on the ground. We are thrilled to recognize Biocon Foundation for their exceptional work in the Healthcare category.”
More About eLAJ Smart Clinic Program
eLAJ Smart Clinics program was launched to strengthen the delivery of evidence-based preventive and primary healthcare. Health outreach is cornerstone of eLAJ, playing a critical role in extending program reach and connecting people to care at our facilities. These smart clinics have been embedded in government Primary Health Centers (PHCs) and further scaled up through partnerships with tertiary institutions and NGOs working at the grassroot levels. Through eLAJ Smart Clinics, Biocon Foundation has been strengthening public healthcare delivery by providing accessible, efficient, and technology-driven healthcare solutions.
The eLAJ Smart Clinics model entails (Information and Communication Technologies) ICT-enabled process innovations, improved diagnostics, and management of non-communicable diseases (NCDs), with strong focus on delivering quality healthcare services to tribal populations in Karnataka. It features an electronic medical record system that provides evidence-based, personalized and continuous care, along with AI-enabled point-of-care diagnostic tools. This is supported by comprehensive surveillance, awareness campaigns, and outreach efforts led by trained and well-equipped health navigators.
Impact assessments have shown that eLAJ model has improved service utilization, patient satisfaction, health awareness and health seeking behavior in patients. It has reduced the out-of-pocket health expenditure for the patients.
With Grant Thornton LLP, Sattva Consulting, Indian School of Development Management, SP Jain Institute of Management and Research and IORA Ecological Solutions as the Primary Screening Partners, the Doing Good for Bharat Awards, ensured fair and thorough evaluation of all applications, ensuring that only the most impactful and innovative initiatives were recognized for their meaningful contributions to society and the environment. This rigorous screening process helped maintain transparency and integrity, highlighting projects that truly embody the spirit of positive change across India.
Biocon Foundation, the Corporate Social Responsibility arm of Biocon, Biocon Biologics and Syngene International, has been working to empower marginalized communities since 2005. Biocon Foundation partners with society to promote social and economic inclusion. It has thus made significant investments in enhancing access to quality healthcare, education, and civic infrastructure along with environmental sustainability projects. Combined with field initiatives, these programs create momentum to elevate the marginalized sections of society. Over the years, Biocon Foundation has built a strong reputation for the quality of its programs and their impact in addressing the social, humanitarian, and environmental challenges facing India. To make a more meaningful impact, the Foundation regularly partners with government agencies and like-minded organizations for program delivery. Besides addressing critical national and state level challenges in primary healthcare, education and rural development, the Foundation is also augmenting environmental sustainability through the lake revival mission in Bengaluru. Visit: http://www.bioconfoundation.org
Curated by CSRBOX and NGOBOX, the India CSR Summit and ESG Forum is Asia’s largest CSR and Sustainability Forum, which brings together leaders from across the social impact spectrum to explore and discuss the evolving landscape of corporate social responsibility (CSR), sustainability and social impact. The three-day event features insightful panel discussions, informative keynote speeches, interactive workshops, and engaging networking opportunities, making it a must-attend event for anyone interested in CSR and sustainability space. The Summit was graced by 3000+ sector visionaries, thought leaders, professionals and change-makers committed to shaping the future of the Indian impact ecosystem through CSR, sustainability, and social impact. Learn more about India

Powered by WPeMatico

How the novel antibody felzartamab impacts IgA nephropathy

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, helps to reduce proteinuria and maintain patients’ kidney function.

Powered by WPeMatico

Analyzing heart and kidney outcomes after canagliflozin treatment in older adults

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients’ age.

Powered by WPeMatico

Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear.

Powered by WPeMatico

Researchers integrate multiple protein markers to predict health outcomes in individuals with chronic kidney disease

Prior efforts to identify novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have typically evaluated proteins individually, which limits their prognostic power.

Powered by WPeMatico

Research finds chronic kidney disease cases in women nearly tripled over 30 years

A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three decades. Also, type 2 diabetes and hypertension were the leading causes of CKD-related deaths in women. The research was presented at ASN Kidney Week 2024 October 23–27.

Powered by WPeMatico

SC Allows MBBS Candidate with 88 percent Muscular Dystrophy to Participate in NEET UG Counselling

New Delhi: Granting relief to a candidate suffering from 88% muscular dystrophy, the Supreme Court bench allowed him to appear in the National Eligibility-Entrance Test 2024 counselling.

The Apex Court bench comprising CJI DY Chandrachud, Justices J B Pardiwala and Manoj Misra granted relief to the MBBS aspirant after Dr. Satendra Singh submitted a report before the top court bench in this regard.

Further, the National Medical Commission (NMC) also submitted before the Court that considering the fact that the petitioner is a bright student having secured 601 marks out of the maximum of 720, he may be permitted to participate in the ongoing counselling process subject to the clarification that the direction of this Court should not be treated as a precedent concluding all issues of law which may arise in any other case.

“We accordingly direct that the appellant be permitted to participate in the ongoing counseling process arising out of NEET UG 2024,” ordered the Apex Court bench.

Medical Dialogues had earlier reported that an MBBS aspirant suffering from 88% Muscular Dystrophy recently approached the Supreme Court after he was disqualified from pursuing the MBBS course. Muscular Dystrophies are a genetically and clinically heterogeneous group of rare neuromuscular diseases causing progressive weakness and breakdown of skeletal muscles over time.

Since the petitioner’s disability was assessed to be more than the permissible limit of 80%, he was disqualified from pursuing MBBS course. However, challenging this decision he approached the Apex Court and based on the court’s order dated 3 October 2024, a five-Member Board of the All India Institute of Medical Sciences submitted a report evaluating the petitioner’s disability.

The said report stated, “The candidate was re-assessed with the assistive device (single hand crutch & motorised scooty). There was minimal to no change in most of the components for disability evaluation as per the GOI gazette (March 2024) with these assistive devices. The possibility of wheelchair usage was also explored which might be required for better efficiency in ambulation component in near future. However, there are no clear guidelines available to assess the disability with assistive devices as per the Govt. of India gazette guideline.”

“Further it is to be noted that safety, efficiency and agility of movements are needed to independently use the devices and many times some manual support is also required which may not be available to the candidate at all times and may affect the safety of the candidate and the patients during the skills based training provided in the various setups in the labs and hospitals during the MBBS course training. The Board after careful evaluations of all possibilities concurs with the opinion of the previous medical board held at AIIMS Nagpur dated 13.08.2024 that the disability is above 80% even with consideration of assistive devices and also both upper limbs have significant involvement and hence the candidate is ineligible to pursue MBBS course,” added the report.

Previously, while considering the matter, the Apex Court bench had noted that the AIIMS Committee had observed in the report that there were no clear guidelines available to assess the disability with assistive devices in terms of the guidelines issued by the Government of India.

Back then, the Court had sought an expert opinion to ascertain whether the candidate suffering from 88% muscular dystrophy is eligible for the MBBS admission, which was beyond the permissible limit of 80%. Accordingly, the top court bench of CJI DY Chandrachud and Justices JB Pardiwala and Manoj Misra had directed Dr. Satendra Singh, the founder of an organisation named Infinite Ability, to take up the matter and assist the court on whether notwithstanding the quantified disability, the petitioner could pursue the MBBS degree course.

Dr. Singh was requested by the top court bench to examine the petitioner and have due regard to such assistive devices and their potential to assist the petitioner to fulfill the requirements of the degree course in medicine. 

Accordingly, Dr. Satendra Singh, Director Professor, University College of Medical Sciences and Guru Teg Bahadur Hospital, University of Delhi submitted a report dated 20 October 2024 before the Court.

During the hearing of the case on October 21, the Court had noted that a copy of the report should be furnished to the counsel for the National Medical Commission (NMC). The Court had also requested the NMC counsel to be present on the next date of hearing to assist the court.

During the hearing of the case on October 25, 2024, the court considered the report which was submitted by Dr. Singh in pursuance of the order dated 18 October 2024.

“The National Medical Commission has fairly stated before this Court that bearing in mind that the appellant is a bright student having secured 601 marks out of maximum of 720, he may be permitted to participate in the ongoing counseling process subject to the clarification that the direction of this Court should not be treated as a precedent concluding all issues of law which may arise in any other case,” noted the Court and allowed the candidate to appear in NEET-UG 2024 counselling.

To read the order, click on the link below:

https://medicaldialogues.in/pdf_upload/order-421542024-25-10-2024-258263.pdf

Also Read: Can a Candidate with 88 percent Muscular Dystrophy Pursue MBBS? Supreme Court Seeks Expert Opinion

Powered by WPeMatico

Delhi AIIMS hosts workshop on AI in healthcare to empower medicos

New Delhi: The premier health institution, the All India Institute of Medical Sciences (AIIMS), New Delhi hosted a workshop centered on emerging technologies, specifically focusing on Artificial Intelligence (AI) to empower healthcare professionals with the skills needed to harness AI’s transformative potential in the medical field.

Dr Kanwalpreet Kochhar, the in-charge of Cognitive Neurophysiology and Nutrition Lab at AIIMS, said the workshop held on Tuesday brought together leading minds in the field of AI and healthcare.

According to the PTI report, she said, “By focusing on practical applications (of AI) and real-world challenges, we are preparing our future healthcare leaders to innovate and improve patient outcomes significantly.”

Also Read:Delhi AIIMS set to be biggest robotic surgery skill training centre: MoS Jadhav

Dr Swadeep Srivastav, founder of healthcare marketing agency Healthpresso, said AI represents a paradigm shift in the approach to healthcare delivery. 

It offers the ability to analyse vast datasets, uncover hidden patterns, and make informed decisions that enhance patient care, he said.

“However, with this power comes responsibility. We must ensure that AI is deployed ethically and equitably, addressing biases and privacy concerns to truly benefit society,” Srivastav said, news agency PTI reported.

Sonia Dosanjh, scientist at the Centre for Development of Advanced Computing (C-DAC), Mohali, highlighted the importance of technological interventions in healthcare.

“AI offers unprecedented opportunities in data-driven decision-making, disease surveillance, and personalized treatment plans. This workshop is a step towards harnessing these opportunities,” she said.

The workshop underscored the need for specialised AI applications in healthcare, such as development of a healthGPT, which would provide tailored solutions by leveraging healthcare-specific data.

Medical Dialogues team had earlier reported that the All India Institute of Medical Sciences (AIIMS) Delhi has launched a groundbreaking initiative with a pilot project in the Mother and Child Block. This project introduces a sophisticated facial recognition-based access control system (FR-ACS) along with a visitor management system (VMS). 

Also Read:Artificial Intelligence for Global Health: Experts to explore AI Integration in advancing Traditional Medicine

Powered by WPeMatico